Skip to main content
search

Dr. Ahmad Sajjadi quoted in JAMA on newly approved blood tests

UCI Health Neurologist and UCI MIND faculty member, Ahmad Sajjadi, MD, PhD, was quoted in the highly cited Journal of the American Medical Association (JAMA) regarding the changing landscape of diagnostics with the approval of the nee blood test for Alzheimer’s disease. Read the article here.

 

 

Related posts:

  1. Dr. Crystal M. Glover will join UCI MIND in 2025 as ORE Core Leader for ADRC We are excited to announce that in January 2025, Dr. Crystal M. Glover will join UCI MIND as the ADRC’s Outreach, Recruitment, and Engagement Core Leader.  She will also serve as Associate Professor of Neurology in the UC Irvine School of Medicine. Dr. Glover is a world-renowned applied social psychologist, mixed...
  2. On the NYT article “What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials” An article in the New York Times is the latest to highlight the safety risks associated with recently approved new treatments for Alzheimer’s disease, lecanemab and donanemab. Being a carrier of the e4 genotype for the apolipoprotein (APOE) gene, is a known risk factor for the most serious side effects...
  3. MIND Matters | Quarterly Newsletter | Fall 2024 ...
Close Menu